NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/25/2026 10:40
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization22,008 mln
Float39.21 mln
Earnings Date11/04/2026
EPS
27.92
Exceptional
P / E
18.59
Moderately valued
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-3.07
Reliable
1-Year Forecast
664
Strong upside
Relative Strength
66
/ 100
Outperforming
Business Description
United Therapeutics is a pharmaceutical company focused on helping people with serious, long-term illnesses that currently have few good treatment options. The company sells several approved medicines for pulmonary arterial hypertension, a life-threatening condition affecting the lungs and heart, as well as a treatment for a rare childhood cancer. Beyond its existing products, United Therapeutics is working on next-generation drug delivery devices and conducting early-stage research into lab-grown and gene-edited animal organs that could one day be transplanted into humans.